Back to top
more

QuidelOrtho (QDEL)

(Delayed Data from NSDQ)

$44.85 USD

44.85
775,431

+0.73 (1.65%)

Updated Sep 11, 2024 03:59 PM ET

After-Market: $45.07 +0.22 (0.49%) 5:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (84 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Ecolab (ECL) Earnings and Revenues Surpass Estimates in Q3

Although Ecolab's (ECL) third-quarter results reflect weakness in the Global Industrial and Institutional segments, its Global Healthcare and Life Sciences unit shows strength.

Is Quidel (QDEL) Stock Outpacing Its Medical Peers This Year?

Is (QDEL) Outperforming Other Medical Stocks This Year?

What's in Store for IDEXX Laboratories (IDXX) in Q3 Earnings?

IDEXX's (IDXX) third-quarter top line is likely to have benefited from strength in CAG and LPD businesses.

Illumina (ILMN) to Report Q3 Earnings: What's in the Offing?

Illumina (ILMN) is upbeat about its third-quarter sequencing consumable revenue growth.

Quidel (QDEL) Outpaces Stock Market Gains: What You Should Know

Quidel (QDEL) closed at $245.74 in the latest trading session, marking a +1.55% move from the prior day.

Quidel (QDEL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Quidel (QDEL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Quest Diagnostics' (DGX) Q3 Earnings Beat, Base Volume Rises

In Q3, Quest Diagnostics (DGX) sees strong signs of the health care system returning to pre-pandemic levels

Align Technology (ALGN) Beats on Q3 Earnings, Margins Up

Align Technology's (ALGN) segments report solid rebound in sales across geographies despite the pandemic-led business challenges.

Edwards Lifesciences (EW) Beats on Q3 Earnings, Margins Up

Despite coronavirus-led business challenges, Edwards Lifesciences (EW) witnessed steady improvement in TAVR procedure volumes in Q3.

Quidel, Akoustis Technologies, Netflix, Snap and Texas Instruments highlighted as Zacks Bull and Bear of the Day

Quidel, Akoustis Technologies, Netflix, Snap and Texas Instruments highlighted as Zacks Bull and Bear of the Day

Kevin Cook headshot

Bull of the Day: Quidel (QDEL)

Rapid COVID-19 tests that also screen influenza A+B have vaulted sales and profit growth 200-400%

Agios (AGIO) Withdraws Filing for Leukemia Drug Tibsovo in EU

Agios (AGIO) withdraws the regulatory filing for Tibsovo in Europe, which was developed to treat relapsed/refractory acute myeloid leukemia in adult patients with a susceptible IDH1 mutation.

Top Ranked Momentum Stocks to Buy for October 16th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 16th

Top Ranked Momentum Stocks to Buy for October 8th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 8th

Kevin Cook headshot

Big October Winners: CRISPR, Alteryx, NVIDIA, Quidel

Two women will share the Nobel prize for a gene editing technology that will change the world.

Has Quidel (QDEL) Outpaced Other Medical Stocks This Year?

Is (QDEL) Outperforming Other Medical Stocks This Year?

Why the Earnings Surprise Streak Could Continue for Quidel (QDEL)

Quidel (QDEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Top Ranked Momentum Stocks to Buy for October 6th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 6th

Kevin Cook headshot

7 Diagnostic and Genomic Stocks Storming Into October

COVID-19 has created an Apollo Mission status for advanced medical technologies and smart investors are profiting.

AngioDynamics (ANGO) Q1 Earnings and Revenues Top Estimates

AngioDynamics (ANGO) witnessed revenue growth across two business segments in fiscal Q1.

Quidel (QDEL) Stock Moves -1.39%: What You Should Know

Quidel (QDEL) closed at $196.21 in the latest trading session, marking a -1.39% move from the prior day.

NEOGEN (NEOG) Q1 Earnings and Revenues Surpass Estimates

NEOGEN's (NEOG) segmental revenues improve for the fiscal first quarter on strong sales of cleaners, disinfectants and sanitizers.

Rockwell Medical (RMTI) Soars: Stock Adds 9.7% in Session

Rockwell Medical (RMTI) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

Is Quidel (QDEL) Stock Outpacing Its Medical Peers This Year?

Is (QDEL) Outperforming Other Medical Stocks This Year?

Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know

Quidel (QDEL) closed the most recent trading day at $159.39, moving -1.12% from the previous trading session.